Est.

Mental Health Parity Compliance for Employer-Sponsored Plans

Employers must document how mental health benefits compare to medical benefits in practice.

· 9 min read
Cover illustration for “Mental Health Parity Compliance for Employer-Sponsored Plans”
Benefits Compliance · November 5, 2026 · 9 min read · 2,019 words

Mental health parity compliance for employer-sponsored plans is an ongoing duty to review plan terms and document how benefits work. Employers must keep nonquantitative treatment limitation comparative analyses that check written rules against how the plan is run. The enforcement pause affecting the 2024 final rule does not remove that statutory obligation.

What MHPAEA actually requires and why the NQTL comparative analysis is the operative obligation

The Mental Health Parity and Addiction Equity Act requires covered plans that provide mental health or substance use disorder benefits to provide them on terms no more restrictive than those applicable to medical and surgical benefits. This duty applies to both financial requirements and treatment limitations. Copayments, coinsurance, and deductibles are visible and relatively straightforward to audit. Process-based restrictions are harder to see. These nonquantitative treatment limitations, or NQTLs, include prior authorization, medical necessity standards, provider network admission standards, and prescription drug formulary design.

The Consolidated Appropriations Act of 2021 amended MHPAEA to expressly require plans to perform and document comparative analyses of NQTL design and application. The analysis must compare the processes, strategies, evidentiary standards, and other factors used for mental health and substance use disorder benefits with those used for medical and surgical benefits. Those factors must be comparable and applied no more stringently, both as written and in operation. The analysis must show restrictions in how the plan is run that may never appear in a benefit summary.

The regulatory status of the 2024 final rule and what baseline obligations remain

Federal agencies announced in May 2025 that they would not enforce the 2024 final rule expanding parity requirements. The announcement followed a lawsuit filed by an employer trade group, and the case was placed on hold while the administration reviewed whether to revise or repeal the rule. The pause has a defined boundary. It applies only to provisions new relative to the 2013 final regulations, while MHPAEA’s statutory obligations remain in force. The 2025 Report to Congress expressly confirmed that the requirement to perform and document comparative analyses continues to have effect.

Labor, Treasury, and HHS told the court on March 30, 2026, that they would not defend the 2024 rule and instead intended to issue a replacement proposed rule by December 31, 2026. The 2013 regulatory framework remains the controlling standard, with the statutory NQTL comparative analysis requirement fully in force. For employers, the practical distinction is between monitoring a potential regulatory change and meeting an existing obligation. Waiting for the replacement proposal before building documentation is not a defensible compliance posture.

How enforcement is actually operating in 2026, and what regulators are looking for

EBSA’s September 8, 2026, guidance identified three enforcement priorities, including separate treatment limitations and exclusions, medical necessity standards and review processes, and network adequacy. The network priority includes admission standards and provider reimbursement methodologies. These priorities reach beyond the benefits printed in a plan document. They examine how access is controlled, how coverage decisions are made, and how providers enter the network. Constrained agency resources may reduce the probability of proactive audits, but they do not reduce the compliance risk when a plan is examined.

The 2025 Report to Congress showed that DOL issued more initial determination letters citing violations while reducing back-and-forth correspondence. Plans therefore had less opportunity to resolve deficiencies before a formal finding. CMS found no comparative analyses sufficient at first submission during the reporting period and provided up to two opportunities for additional information before making an initial compliance determination. Initial adequacy was not simply uncommon in that review. It was absent.

EBSA has devoted nearly a quarter of its overall enforcement program to NQTL comparative analysis review. Parity corrections have removed barriers for more than 7.6 million participants across tens of thousands of plans. That scope shows why agency constraints should not be read as a reason to delay preparation. The September guidance also helps employers check their own plans by showing the warning signs regulators look for in how plans are run.

The seven warning signs EBSA uses to flag a plan for review

EBSA’s first warning sign is a plan that excludes mental health or substance use disorder treatments when it covers comparable medical care. DOL points to autism treatments and medications used to treat substance use disorders. The employer’s question is direct. Does our plan exclude any MH/SUD treatments that would be covered in a comparable medical situation?

The second warning sign is prior authorization applied more restrictively to mental health care than to comparable medical and surgical care. Are prior authorization requirements applied differently to behavioral health benefits than to medical benefits?

The third warning sign is medical necessity standards harder to meet for mental health. More frequent reviews, additional documentation requirements, or stricter criteria applied only to behavioral health can reveal the disparity. How does our plan determine medical necessity for mental health care, and how does that compare with medical and surgical care?

The fourth warning sign is employees cannot find in-network mental health providers. Indicators include longer wait times, fewer network-gap efforts, difficult out-of-network exception processes, disproportionately high out-of-network use, and elevated employee complaints. Can employees actually find available in-network mental health providers within a reasonable time?

The fifth warning sign appears when mental health providers face different credentialing processes or reimbursement methodologies, or find it harder to join or stay in the network. These restrictions are outside the plan documents that participants see. How does our carrier evaluate, recruit, and reimburse mental health providers compared with medical providers?

The sixth warning sign is disparities in out-of-network exception procedures. A more burdensome single-case agreement or network-gap exception process for mental health care is itself an NQTL. Are out-of-network exception processes applied comparably to behavioral health and medical care?

The seventh warning sign is step therapy or formulary design applied asymmetrically to behavioral health medications versus comparable medical treatments. This extends the review into prescription drug administration. A pharmacy benefit cannot be treated as outside the parity review merely because a separate vendor manages it.

Where TPA and vendor relationships create hidden compliance liability

Outsourcing administration does not outsource the plan sponsor’s obligation. The 2025 Report to Congress documented one service provider’s use of outdated legacy systems that were noncompliant with MHPAEA across multiple plans. Those failures required reprocessing and payment of previously denied claims. The report also documented a provider administering an ABA therapy exclusion to self-funded plans that covered Autism Spectrum Disorder as a mental health benefit. DOL has long signaled that this is a de facto MHPAEA violation.

The ABA example also exposes the limits of state protections. Almost every state requires insurers to cover autism treatment, but state insurance mandates do not reach self-funded ERISA plans. Federal parity is therefore the only protection for most covered workers in that setting. A sponsor cannot infer compliance from protections that apply to insured coverage. Nor can it assume that a vendor’s internal administration documents match the plan documents and summaries given to participants.

For employers, the response is to request evidence from every relevant administrator. Sponsors should proactively discuss parity obligations with service providers, request and review comparative analyses from TPAs and PBMs, and confirm that internal administration documents match participant-facing documents and SPDs. A separate prescription drug benefit requires analysis tied to the PBM’s practices. Any third party writing the analysis must understand both plan design and how the plan works in practice. An assurance of compliance cannot substitute for that documentation.

How funding structure — self-funded versus fully insured — determines who bears the obligation and how directly

For self-funded plans, the employer is the plan sponsor with full MHPAEA obligations, and DOL audits the employer directly. ERISA preempts state insurance law, limiting state insurance regulators’ authority over these plans. With fully insured coverage, the insurer has the main responsibility for MHPAEA compliance. The employer still has a real, though smaller, duty to check compliance through plan documents and the terms of its contracts.

The majority of Americans with employer-sponsored coverage are in self-funded plans, which explains the breadth of direct sponsor exposure. Self-insured plans sponsored by employers with 50 or fewer employees are exempt from mental health parity requirements. That exemption disappears when the company crosses the threshold. Treasury penalty exposure for violations is $100 per day per affected individual, so a short noncompliance period can compound quickly across several hundred employees.

A PEO exit can make this shift particularly abrupt. When a company leaves a PEO’s fully insured master plan for self-funded coverage, it takes on direct responsibility as the ERISA plan sponsor where the carrier had taken the lead. Self-funding’s design flexibility and cost savings come with NQTL documentation duties that early-stage HR teams may not have operationalized. For a company making that transition, parity documentation becomes part of establishing its own compliance function.

What a defensible NQTL comparative analysis actually contains

A defensible analysis identifies the restriction and documents the basis for applying it to both benefit categories. It sets out the relevant processes, strategies, evidentiary standards, and other factors, then compares their written design and actual application. A benefit summary is not enough. For example, even when written prior authorization terms comply, they cannot make up for more restrictive handling of behavioral health claims. The documentation must address the rule that employees actually encounter.

DOL’s most-requested analyses in the 2025 report covered provider network admission standards, exclusions of speech or occupational therapy, limits on autism services, exclusions of nutritional counseling, and exclusions of ABA therapy. Limits on autism services included age limits and requirements for parents to take part, which were separate from an outright ABA exclusion. CMS most often requested analyses of prior authorization, medical necessity, precertification, concurrent review, and medical management standards for experimental or investigational treatments. These requests help sponsors decide what to document first. They also show why one general statement about parity cannot cover the range of restrictions under review.

To build that record, employers should require the analysis to cover each carveout arrangement on its own, including how a PBM handles pharmacy benefits. Network documentation should compare credentialing standards, reimbursement methodologies, and efforts to recruit behavioral health providers against equivalent medical standards. Carrier management of the network does not establish parity. A consultant preparing the analysis must know the specific plan’s operations and NQTL application. Initial drafts should be treated as work subject to revision.

Building the ongoing compliance process rather than treating documentation as a one-time project

A comparative analysis becomes stale when the practices it describes change. A change in a TPA system, revised medical management criteria, a new formulary, or different network admission standards can create a parity gap even when the plan document stays the same. Open enrollment documentation is therefore only a snapshot. The review process must link checks of written terms with checks of how the plan is run. Otherwise, the plan may retain an analysis that no longer describes how benefits work.

For employers, that means establishing a standing renewal process before a DOL inquiry. Each year, employers should ask all service providers for updated analyses and compare TPA administration documents with plan documents and SPDs. The review should examine network wait times, out-of-network utilization, and employee complaint patterns, while testing prior authorization and medical necessity workflows for asymmetric application. The review must still cover pharmacy and behavioral health carveouts. Employers should use EBSA’s warning signs as a self-audit tool and retain documentation of each review as evidence of a good-faith compliance process.

Regulatory monitoring belongs in that cycle as well. Employers should watch for the replacement proposed rule due by December 31, 2026, and check whether its new provisions call for changes to analyses or plan design. For companies newly self-funding after a PEO exit or crossing the 50-employee threshold, the first review establishes the baseline regulators would request. Advisor accountability belongs in the same process, because identifying documentation gaps creates work that may not generate additional compensation for a commission-driven broker. The question for any benefits advisor is what the advisor is doing to monitor and document parity compliance to support a claim that the plan “is compliant.

Sources

  1. The 2025 Mental Health Parity Report to Congress: Practical Takeaways for Plan Sponsors
  2. Mental Health Parity

More in Benefits Compliance